Herantis Pharma Oyj (HEL:HRTIS)
Finland
· Delayed Price · Currency is EUR 1.890
-0.100 (-5.03%)
Mar 9, 2026, 6:23 PM EET
Herantis Pharma Oyj Revenue
In the year 2025, Herantis Pharma Oyj had annual revenue of 178.00K EUR.
Revenue
178.00K
Revenue Growth
n/a
P/S Ratio
281.42
Revenue / Employee
13.69K
Employees
13
Market Cap
50.09M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.89B |
| Terveystalo Oyj | 1.28B |
| Revenio Group Oyj | 109.90M |
| Pihlajalinna Oyj | 652.30M |
| Nightingale Health Oyj | 4.79M |
| Aiforia Technologies Oyj | 4.08M |
| Nexstim | 12.41M |
| Nanoform Finland Oyj | 5.02M |
Herantis Pharma Oyj News
- 2 months ago - Herantis Pharma Oyj Phase 1b Biomarker Data Transcript - GuruFocus
- 2 months ago - Herantis Pharma Oyj (HRPMF) Discusses Phase 1b Biomarker Data for HER-096 in Parkinson's Disease and Implications for Clinical Development Transcript - Seeking Alpha
- 5 months ago - Herantis Pharma Oyj (HRPMF) Presents at Nordic Life Science Days 2025 - Slideshow - Seeking Alpha
- 5 months ago - Herantis Pharma Oyj (HRPMF) Announcement of Positive Topline Results from Phase 1b Trial of HER-096 Transcript - Seeking Alpha
- 5 months ago - Herantis Pharma Oyj - Special Call - Seeking Alpha